$MS — BUY 📊 | 6 MONTHS THESIS

$MS — BUY 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $20.6B | EPS $3.43 vs $3.02 🟢 💡 Consensus expected EPS $3.02; actual $3.43 (13.5% beat). The market may not fully price in the positive revision cycle and multiple expansion as MS demonstrates sustained high returns. 📉 Reward/risk: 2.2:1 🏢 Business Quality: 8/10 📊 Valuation: fair — current PE 18.8x at median historical, but ROTCE 27% justifies premium vs peers; using 20x multiple on annualized Q1 EPS of $13.72 yields $274... 🔮 Catalyst: Next quarterly earnings and wealth management asset flows disclosures 💰 Entry: $223, stop $200, target $274 ⚖️ Buy MS on a post-earnings beat with a 3-month target of $274, driven by wealth management momentum and re-rating potential. 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/MS0620

🎯 Q1 2026 | Rev $20.6B | EPS $3.43 vs $3.02 🟢